RenovoRx Investor Relations Material
Latest events
Q2 2025
RenovoRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from RenovoRx Inc
Access all reports
RenovoRx Inc is a U.S.-based medical technology company focused on targeted drug delivery systems. It develops catheter-based platforms for the localized administration of chemotherapy and other therapeutics, primarily for treating cancers. The company aims to improve patient outcomes by reducing systemic exposure and enhancing precision in treatment delivery. It is headquartered in Los Altos, California, and its shares are listed on the NASDAQ.
Key slides for RenovoRx Inc
Investor Presentation
RenovoRx Inc
Investor Presentation
RenovoRx Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
RNXT
Country
🇺🇸 United States